These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15485343)

  • 21. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Michigan genetics plan: a report on the needs assessment process.
    Beene-Harris R; Bach JV
    Health Promot Pract; 2009 Apr; 10(2):201-9. PubMed ID: 19372281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic screening--part of tomorrow's medicine].
    Aula P; Palotie L
    Duodecim; 1991; 107(23-24):1961-3. PubMed ID: 1366104
    [No Abstract]   [Full Text] [Related]  

  • 24. [Genetic diagnosis of hereditary diseases].
    Narisawa K
    Nihon Naika Gakkai Zasshi; 1998 Nov; 87(11):2322-8. PubMed ID: 9921221
    [No Abstract]   [Full Text] [Related]  

  • 25. Naming and counting disorders (conditions) included in newborn screening panels.
    Sweetman L; Millington DS; Therrell BL; Hannon WH; Popovich B; Watson MS; Mann MY; Lloyd-Puryear MA; van Dyck PC
    Pediatrics; 2006 May; 117(5 Pt 2):S308-14. PubMed ID: 16735257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening for genetic disorders.
    Fernhoff PM
    Pediatr Clin North Am; 2009 Jun; 56(3):505-13, Table of Contents. PubMed ID: 19501689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded newborn screening: implications for genomic medicine.
    McCabe LL; McCabe ER
    Annu Rev Med; 2008; 59():163-75. PubMed ID: 18186702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal and newborn screening for hemoglobinopathies.
    Hoppe CC
    Int J Lab Hematol; 2013 Jun; 35(3):297-305. PubMed ID: 23590658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.
    Garg U; Dasouki M
    Clin Biochem; 2006 Apr; 39(4):315-32. PubMed ID: 16563365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of the spectrum of genetic diseases in Bahrain.
    al-Arrayed SS
    East Mediterr Health J; 1999 Nov; 5(6):1114-20. PubMed ID: 11924098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening and genetic testing.
    Kenner C; Moran M
    J Midwifery Womens Health; 2005; 50(3):219-26. PubMed ID: 15895000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population screening: report of a workshop.
    Scriver CR
    Prog Clin Biol Res; 1985; 163B():89-152. PubMed ID: 2580316
    [No Abstract]   [Full Text] [Related]  

  • 34. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best practices: antenatal screening for common genetic conditions other than aneuploidy.
    Ram KT; Klugman SD
    Curr Opin Obstet Gynecol; 2010 Apr; 22(2):139-45. PubMed ID: 20125016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are we ready for universal genetic screening?
    Simpson JL
    Reprod Biomed Online; 2010 Oct; 21(4):437-9. PubMed ID: 20813585
    [No Abstract]   [Full Text] [Related]  

  • 37. Population screening for carrier status: effects of test limitations on precision of carrier prevalence rates.
    Parker RA; Phillips JA
    Am J Med Genet; 1994 Feb; 49(3):317-22. PubMed ID: 8209893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ethical and psychological aspects of screening tests for children].
    Dehlholm G; Hansen D
    Nord Med; 1993; 108(11):297-9. PubMed ID: 8247721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of newborn screening in the era of tandem mass spectrometry: what's new for the pediatric neurologist?
    Copeland S
    Semin Pediatr Neurol; 2008 Sep; 15(3):110-6. PubMed ID: 18708000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of new genetic diseases into statewide newborn screening: New England experience.
    Comeau AM; Larson C; Eaton RB
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):35-41. PubMed ID: 14755432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.